Tweets | @Ultimovacs
Press Releases
Ultimovacs Announces Updated Positive Results from Phase I Trial Evaluating Universal Cancer Vaccine, UV1, in Non-Small Cell Lung Cancer
19, October, 2020
Ultimovacs Announces Positive Topline Results from Phase I Combination Trial Evaluating Universal Cancer Vaccine, UV1, in Malignant Melanoma Patients
30, September, 2020
Ultimovacs ASA Announces Completion of Patient Enrollment in Phase I Trial in Malignant Melanoma
18, August, 2020
See all
News
BioStock has published the article: “Ultimovacs in the fight against Melanoma”:
8, October, 2020
“Melanoma is the deadliest form of skin cancer. As such, new treatments for the disease are in strong demand. Norwegian […]
BioStock has published an in-depth article on Ultimovacs
24, September, 2020
“Cancer’s heavy burden on society has created a strong demand for new innovative therapeutic solutions. Over the last decade, immunotherapy […]
Article in HealthTalk covering the Topline Results from Phase I Combination Trial Evaluating Universal Cancer Vaccine, UV1, in Malignant Melanoma Patients
2, October, 2020
See all
“Ultimovacs med lovende overlevelsesdata på pasienter med føflekkreft som fikk kreftvaksinen UV1 i kombinasjon med immunterapi Ultimovacs har nå gått […]